PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: International Society Pharmaceutical Engineer

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Risk-based Control Strategies in Pharmaceutical Industries at ISPE Brussels Conference - Global launch of Baseline® Guide: Risk-MaPP at the ISPE Brussels Conference in Brussels, Belgium, 20-23 September. Attendees will receive a complimentary copy of the Guide with paid registration
Risk-based Control Strategies in Pharmaceutical Industries at ISPE Brussels Conference

 

NewswireToday - /newswire/ - Tampa, FL, United States, 2010/07/22 - Global launch of Baseline® Guide: Risk-MaPP at the ISPE Brussels Conference in Brussels, Belgium, 20-23 September. Attendees will receive a complimentary copy of the Guide with paid registration.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

ISPE, a global not-for-profit association of 23,000 pharmaceutical science and manufacturing professionals, will be hosting the ISPE Brussels Conference – Risk-based Control Strategies in Pharmaceutical Industries – at the Sheraton Brussels Hotel in Brussels, Belgium, 20-23 September 2010.

The ISPE Brussels Conference will be the global launch of the Baseline® Guide: Risk-Based Manufacture of Pharmaceutical Products (Risk-MaPP). Attendees will receive a complimentary copy of the Guide with paid registration. In preparation for the Risk-MaPP Seminar, it is encouraged that delegates attend a Live Webinar ‘Risk-MaPP: What it is and Why You Need it!’ on 14 September 2010.

Risk-MaPP provides a scientific risk-based approach, based on ICH Q9, to manage the risk of cross contamination in order to achieve and maintain an appropriate balance between product quality and operator safety. If you are involved with multi-product facilities, this document is an essential tool in understanding and control the risk of cross contamination, while also protecting the operator.

The conference will provide industry professionals the opportunity to learn from leaders and innovators from across the globe. The conference seminars and training courses include:

Conference Seminars

• Barrier Isolation Technology Forum: Innovation, Updates, New Case Studies;
• Dedicated Facilities, Cross Contamination and the Risk-MaPP Approach;
• GAMP: A Guided Tour of the World of Good Practice Guides;
• PQLI: Case Studies in QbD for Biotechnology and Small Molecule Product Realisation;
• Containment: The Devil is in the Detail;
• Investigational Products (IP): Lean and Compliant Applying Efficient Tools to a Regulated Clinical Supply Chain;
• Science and Risk-Based Commissioning and Qualification (C&Q): Transitioning and Transforming.

Training Courses

• Sterile Drug Manufacturing Facilities: Applying ISPE Baseline® Guide and FDA Guidance Principles to Design and Operation.
• Practical Application of Computerised Systems Compliance GAMP® 5 (includes online course).

In addition, the event will include sponsorship and tabletop exhibits of the industry’s top suppliers of pharmaceutical manufacturing, and networking events for pharmaceutical industry professionals.

For complete conference seminar and training course information, or to register for the ISPE 2010 Brussels Conference, call ISPE Members Services at +32 2 743 44 22.

For sponsorship and tabletop exhibit information, contact Elmarie Herloff-Petersen, by T: +32 2 789 2337 or email Elmarie.Herloff-Petersen[.]mic-group.com.

For press passes to attend this event, contact Ryan Smith, ISPE Communications Manager.

About ISPE
ISPE (ispe.org), the International Society for Pharmaceutical Engineering, is the Society of choice for 23,000 technical professionals working in or serving the manufacturing sector or drug development in the pharmaceutical industry in 90 countries. ISPE aims to be the catalyst for "Engineering Pharmaceutical Innovation" by providing Members with opportunities to develop their technical knowledge, exchange practical experience within their community, enhance their professional skills, and collaborate with global regulatory agencies and industry leaders. Founded in 1980, ISPE offers online learning opportunities for a global audience and has its worldwide headquarters in Tampa, Florida, USA; its European office in Brussels, Belgium; an Asia Pacific office in Singapore; and its newest office in Shanghai, China.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: International Society Pharmaceutical Engineer

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Risk-based Control Strategies in Pharmaceutical Industries at ISPE Brussels Conference

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Ryan Smith - ISPE.org 
813-960-2105 rsmith[.]ispe.org
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any International Society Pharmaceutical Engineer securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From International Society Pharmaceutical Engineer / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

Commodity Chemicals Market Projected to be Resilient by 2020 Says Persistence Market Research
Cell Expansion Market Set to Garner Staggering Revenues by 2025 Reports PMR
Soft Tissue Sarcoma Treatment Market Revenue Predicted To Go Up by 2025 Finds Persistence Market Research
Persistence Market Research Publishes Biopharmaceutical Membrane Filtration Market Forecast Over 2017-2025
Global Tablet Processing & Packaging Equipment Market to Reach USD 5,268.8 Million by 2022
FDA Approves Genentech’s Actemra (Tocilizumab) for Giant Cell Arteritis
BTG and HealthLoop Collaborate on IO Loop™ - An Exclusive Service to Connect Patients and Interventional Oncologists throughout Treatment
BD and UniteOR Join Forces to Deliver an Integrated Tracking Solution for the Operating Room Setting
MDxHealth and Maastricht University Collaborate on Next Generation (Epi)genetic Cancer Diagnostics
BD to Invest $60 Million in Nebraska Manufacturing Facility
MDxHealth Announces New Contract with MediNcrease Health Plans Regarding ConfirmMDx and SelectMDx
Pulse Certified As A Level Four Multichannel Content Agency by Veeva
Earthly Mist - Opioid-Alternative Painkiller, Kratom Now Available in Oklahoma City
MDxHealth and Exact Sciences Sign Collaboration Agreement
BD Advances Efforts to Combat Antimicrobial Resistance with Enhanced Diagnostic Solution Offering

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  Persistence Market Research (P) Ltd

Visit  JobsWare.com





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)